TD Cowen analyst William Katz maintained a Hold rating on Artisan Partners (APAM – Research Report) today and set a price target of $46.00. The ...
TD Cowen has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to hold from sell, stating it now sees less downside to the stock. "We believe Casgevy expectations have bottomed out in the near term and ...
Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will present at the TD Cowen 46th Annual ...
TD Cowen lowered the firm’s price target on Lyft (LYFT) to $14 from $16 and keeps a Hold rating on the shares. The firm said 4Q GBs were 1.0% ...
Canada’s telecom sector has been under pressure, but is the operating environment beginning to improve? TD Cowen's Vince ...
Investing.com -- TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech company completed its $600 million acquisition of Ambry ...
Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...
TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...
Salesforce has been upgraded to a Buy from TD Cowen analysts, who also raised their price target to $400 per share citing the year-end stock rally tied to the deployment of the Agentforce AI product ...
TD Cowen analyst William Katz maintained a Buy rating on Invesco (IVZ – Research Report) today and set a price target of $22.00. The company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback